What are the potential causes and treatment options for Pyrexia of Unknown Origin (PUO) in an adult patient with no significant past medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pyrexia of Unknown Origin (PUO): Causes and Management

Definition and Initial Diagnostic Workup

PUO is defined as fever ≥38.3°C lasting at least three weeks with no cause identified after three days of inpatient investigation or three outpatient visits. 1

Immediate Actions

  • Obtain blood cultures from peripheral vein and all indwelling catheters before starting any antimicrobials 2
  • Perform complete blood count with differential to assess for neutropenia (ANC <0.5 × 10^9/L indicates severe neutropenia requiring immediate broad-spectrum antibiotics) 2
  • Order chest imaging (X-ray or CT) for respiratory symptoms or persistent fever 2

Major Causes of PUO

The causes fall into four broad categories, with specific entities to actively investigate 3, 1:

Infectious Causes

  • Tuberculosis remains a leading cause, particularly in HIV-positive patients, and can affect any organ system 4
  • Bacterial infections including occult abscesses, endocarditis, and osteomyelitis 3
  • Viral infections (HIV, CMV, EBV) 3
  • Fungal infections in immunocompromised patients 2

Inflammatory/Autoimmune Causes

  • Inflammatory bowel disease (Crohn's disease) can present as PUO with minimal gastrointestinal symptoms in young adults 5
  • Connective tissue diseases (systemic lupus erythematosus, rheumatoid arthritis, vasculitis) 3
  • Sarcoidosis 4

Neoplastic Causes

  • Lymphomas (Hodgkin's and non-Hodgkin's) 3
  • Leukemias 3
  • Solid tumors with metastases 4

Miscellaneous Causes

  • Drug-induced fever (BRAF inhibitors commonly cause pyrexia 2-4 weeks after initiation) 6
  • Thromboembolic disease 3

Systematic Investigation Strategy

History Taking Priorities

Take a detailed medication history to identify drug-induced causes (immunosuppressants, BRAF inhibitors, chemotherapy agents) 6

Document environmental exposures at home, work, and frequently visited places: specifically ask about mold, birds, down feathers, animals, metal dusts, wood dust, livestock, and recent occupational changes 6

Laboratory Testing Sequence

First-tier tests: 2, 3

  • Blood cultures (multiple sets from different sites)
  • CBC with differential and absolute neutrophil count
  • Comprehensive metabolic panel
  • Inflammatory markers (ESR, CRP)
  • Urinalysis and urine culture

Second-tier serological testing if connective tissue disease suspected: 6

  • ANA, RF, anti-CCP antibodies
  • Anti-dsDNA, complement levels (C3, C4)
  • Creatine phosphokinase, myoglobin, aldolase
  • Antisynthetase antibodies (Jo-1)
  • Anti-Scl-70/topoisomerase-1 for scleroderma
  • Anti-SSA/Ro and anti-SSB/La for Sjögren syndrome
  • ANCA for vasculitis

Advanced Imaging

For prolonged unexplained fever beyond initial workup, FDG-PET/CT should be performed as it has high sensitivity and specificity for detecting infections, inflammatory processes, and occult malignancies 2, 4

High-resolution chest CT is indicated if fungal infection suspected, looking for nodules with haloes or ground-glass changes 2, 7

Management Algorithm Based on Clinical Scenario

Severe Neutropenia (ANC <0.5 × 10^9/L)

Initiate broad-spectrum antibacterial therapy immediately without waiting for culture results 2, 7

Do not delay antimicrobial therapy while awaiting diagnostic workup 2, 7

Persistent Fever >4-6 Days Despite Antibiotics

Consider initiating empiric antifungal therapy (voriconazole or liposomal amphotericin B for suspected aspergillosis) 2, 7

Perform bronchoalveolar lavage if infiltrates found on imaging 2

Low-Risk Patients with Recovered Neutrophil Counts

For patients with ANC ≥0.5 × 10^9/L at 48 hours who are afebrile and asymptomatic, consider switching to oral antibiotics or discontinuing aminoglycosides 2

Avoid unnecessary antibiotic continuation in recovered, afebrile patients 2

Stable Patients with No Diagnosis After Extensive Workup

In stable patients without progressive disease, careful clinical observation for new symptoms is preferred over empiric antimicrobial courses 8

Up to 50% of PUO cases remain undiagnosed despite adequate investigation, but this cohort has a good prognosis 3

Critical Pitfalls to Avoid

Signs and symptoms of infection may be minimal or absent in neutropenic patients, especially those on corticosteroids—maintain high suspicion even with low-grade fever 7

BRAF inhibitor-induced pyrexia typically occurs 2-4 weeks after starting therapy and requires drug discontinuation plus antipyretics (acetaminophen/NSAIDs), not antibiotics 6

Consider colonoscopy if abdominal CT shows bowel wall thickening, as inflammatory bowel disease can present as PUO with minimal GI symptoms 5

Thrombocytopenia may preclude invasive diagnostic procedures—assess risk-benefit and consider platelet transfusion before procedures 7

References

Guideline

Management of Pyrexia of Unknown Origin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pyrexia of unknown origin.

Clinical medicine (London, England), 2018

Research

FDG PET/CT in evaluation of pyrexia of unknown origin.

Clinical nuclear medicine, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis of Febrile Neutropenia with Thrombocytopenia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pyrexia of unknown origin--approach to management.

Singapore medical journal, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.